Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate efficacy (clinical benefit) of two doses of ZK PRA (25 mg and 100 mg) when administered once daily p.o.
Critère d'inclusion
- Metastatic breast cancer
To evaluate efficacy (clinical benefit) of two doses of ZK PRA (25 mg and 100 mg) when administered once daily p.o.